Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma

Overview of attention for article published in Frontiers in oncology, January 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 30 X posts from 23 X users, with an upper bound of 101,420 followers.

RT @chioseasi: .@chioseasi spinal mass, tiny bx, KIAA1549/BRAF+ fusion-pilocytic astrocytoma?! https://t.co/qkzkvQu3wV https://t.co/0Pk2mj…

RT @chioseasi: .@chioseasi spinal mass, tiny bx, KIAA1549/BRAF+ fusion-pilocytic astrocytoma?! https://t.co/qkzkvQu3wV https://t.co/0Pk2mj…

RT @chioseasi: .@chioseasi spinal mass, tiny bx, KIAA1549/BRAF+ fusion-pilocytic astrocytoma?! https://t.co/qkzkvQu3wV https://t.co/0Pk2mj…

RT @chioseasi: .@chioseasi spinal mass, tiny bx, KIAA1549/BRAF+ fusion-pilocytic astrocytoma?! https://t.co/qkzkvQu3wV https://t.co/0Pk2mj…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 26 additional X posts.